Medicure Company Profile (OTCMKTS:MCUJF)

About Medicure (OTCMKTS:MCUJF)

Medicure logoMedicure Inc. (Medicure) is a pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. The Company operates in the biopharmaceutical industry segment. The Company's primary operating focus is on the sale and marketing of its acute care cardiovascular drug, AGGRASTAT (tirofiban hydrochloride) owned by its subsidiary, Medicure International, Inc. and distributed in the United States and its territories through the Company's United States subsidiary, Medicure Pharma, Inc. AGGRASTAT, a glycoprotein IIb/IIIa inhibitor (GPI), is used for the treatment of acute coronary syndrome (ACS). The Company is also engaged in the development of TARDOXAL for neurological disorders, such as Tardive Dyskinesia (TD). The Company has completed Phase IIa stage of development for TARDOXAL. The Company is also developing Transdermal AGGRASTAT, a cure for acute cardiology. Transdermal AGGRASTAT is in preclinical-stage of development.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: N/A
  • Sub-Industry: N/A
  • Symbol: OTCMKTS:MCUJF
  • CUSIP: N/A
  • Web: www.medicure.com
Capitalization:
  • Market Cap: $101.15 million
  • Outstanding Shares: 15,566,000
Average Prices:
  • 52 Week Range: $4.11 - $7.96
P/E:
  • Trailing P/E Ratio:
  • Foreward P/E Ratio: 7.19
  • P/E Growth:
Sales & Book Value:
  • Annual Revenue: $31.97 million
  • Price / Sales: 3.15
  • Book Value: $1.57 per share
  • Price / Book: 4.12
Profitability:
  • EBIDTA: $7.07 million
  • Net Margins: 53.57%
  • Return on Equity: 97.72%
  • Return on Assets: 19.60%
Debt:
  • Debt-to-Equity Ratio: 1.71%
  • Current Ratio: 0.60%
  • Quick Ratio: 0.37%
Misc:
  • Average Volume: 1,679 shs.
  • Beta: 0.58
  • Short Ratio: 1.77
 
Frequently Asked Questions for Medicure (OTCMKTS:MCUJF)

What is Medicure's stock symbol?

Medicure trades on the OTCMKTS under the ticker symbol "MCUJF."

How were Medicure's earnings last quarter?

Medicure Inc. (OTCMKTS:MCUJF) issued its quarterly earnings data on Wednesday, November, 9th. The company reported $0.09 earnings per share (EPS) for the quarter. The company earned $6.29 million during the quarter. Medicure had a return on equity of 97.72% and a net margin of 53.57%. View Medicure's Earnings History.

Who are some of Medicure's key competitors?

Who are Medicure's key executives?

Medicure's management team includes the folowing people:

  • Albert D. Friesen Ph.D., Chairman of the Board, President, Chief Executive Officer
  • James F Kinley CA, Chief Financial Officer, Secretary
  • Brent Fawkes, Director
  • Gerald P. McDole, Independent Director
  • Arnold Naimark, Independent Director
  • Peter Quick, Independent Director

How do I buy Medicure stock?

Shares of Medicure can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Medicure's stock price today?

One share of Medicure stock can currently be purchased for approximately $6.47.


MarketBeat Community Rating for Medicure (OTCMKTS MCUJF)
Community Ranking:  4.0 out of 5 (   )
Outperform Votes:  12 (Vote Outperform)
Underperform Votes:  3 (Vote Underperform)
Total Votes:  15
MarketBeat's community ratings are surveys of what our community members think about Medicure and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Medicure (OTCMKTS:MCUJF) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Medicure (OTCMKTS:MCUJF)
Show:
DateFirmActionRatingPrice TargetDetails
1/13/2016MackieReiterated RatingBuy$8.00View Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for Medicure (OTCMKTS:MCUJF)
Earnings by Quarter for Medicure (OTCMKTS:MCUJF)
Earnings History by Quarter for Medicure (OTCMKTS MCUJF)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/9/2016Q3 2016$0.09$6.29 millionViewN/AView Earnings Details
1/28/2014Nov 2013($0.04)$0.78 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Medicure (OTCMKTS:MCUJF)
Current Year EPS Consensus Estimate: $0.46 EPS
Next Year EPS Consensus Estimate: $0.9 EPS

Dividends

Dividend History for Medicure (OTCMKTS:MCUJF)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Medicure (OTCMKTS:MCUJF)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Headline Trends for Medicure (OTCMKTS:MCUJF)
Latest Headlines for Medicure (OTCMKTS:MCUJF)
Source:
DateHeadline
americanbankingnews.com logoMedicure Inc. (MCUJF) Raised to "Strong-Buy" at ValuEngine
www.americanbankingnews.com - June 17 at 7:52 PM
us.rd.yahoo.com logo1:02 pm Medicure announces that an abbreviated New Drug Application was filed with the FDA for a high-value cardiovascular generic drug developed in collaboration with Apicore
us.rd.yahoo.com - December 15 at 5:12 AM
finance.yahoo.com logoMedicure announces filing of ANDA in collaboration with Apicore
finance.yahoo.com - December 13 at 6:54 PM
finance.yahoo.com logo7:13 am Medicure receives complete response letter from the FDA on its AGGRASTAT sNDA
finance.yahoo.com - July 8 at 7:13 AM
finance.yahoo.com logoMedicure posts 1Q profit
finance.yahoo.com - May 12 at 7:53 AM
finance.yahoo.com logoMedicure Reports First Quarter 2016 Financial Results
finance.yahoo.com - May 11 at 5:00 PM
finance.yahoo.com logoMedicure Files Application for New AGGRASTAT® Product Format
finance.yahoo.com - May 11 at 8:00 AM
finance.yahoo.com logoMedicure Announces Grant of Options
finance.yahoo.com - April 7 at 4:25 PM
cnbc.com logoMedicure posts 4Q profit
www.cnbc.com - March 31 at 7:12 AM
thestreet.com logoMeta-Analysis Of AGGRASTAT® (Tirofiban HCl) Presented At CRT 2016 Conference
www.thestreet.com - February 23 at 3:30 PM
finance.yahoo.com logoMedicure Announces Preliminary Revenue For Fiscal 2015
finance.yahoo.com - January 11 at 9:30 AM
finance.yahoo.com logoMedicure announces ANDA collaboration with Apicore
finance.yahoo.com - January 6 at 8:00 AM
finance.yahoo.com logoMEDICURE INC Financials
finance.yahoo.com - December 8 at 1:09 PM
finance.yahoo.com logoMedicure Announces Grant of Stock Options
finance.yahoo.com - November 25 at 5:55 PM

Social

Chart

Medicure (MCUJF) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff